EXCLUSIVE: Two-time Oscar nominee Bette Midler has inked a deal to star alongside Jonah Hill and Kristen Wiig in Cut Off, the new comedy that Jonah Hill co-wrote and will direct for Warner Bros.

Jonah Hill was everywhere in the 2010s. After breaking through with his hilarious performance in the now-seminal, near-perfect 2007 teen comedy Superbad, Hill booked a bunch of lead and/or prestige ...

Andy Cohen is admitting to dabbling in the world of weight loss drugs. The "Real Housewives" executive producer opened up about "micro-dosing" on an unnamed GLP-1 weight loss drug on his SiriusXM ...

The singer addressed the ongoing speculation that she takes weight-loss medication in "IDGAS," a track from her new album, 'My Face Still Hurts from Smiling' Cara Lynn Shultz is a writer-reporter at ...

The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do ...

Lizzo is feeling good as hell. More than two years after she began slimming down amid a wellness journey, the 37-year-old released a new song clapping back at her critics, including those who have ...

Researchers believe they may have the next, better version of Ozempic in the works. At Tufts University, scientists have developed a new drug that aims to boost weight loss while also reducing the ...

We've all heard about the uncomfortable side effects that come with taking GLP-1 medications like Ozempic and Wegovy: upset stomach, constipation, nausea, hair loss... The list goes on. But ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X The music artist, 37, posted a new video dressed in a slinky pink-trimmed number and black fuzzy ...

DHA's decision to end the coverage violates DOD's own regulations regarding Tricare for Life beneficiaries, the author of this op-ed argues. (Sebastien Bozon/AFP via Getty Images) At 69 years old, ...

HOUSTON — A retrospective study presented at the Society of Hematologic Oncology (SOHO) 2025 suggested that glucagon-like peptide-1 receptor agonists (GLP-1s) such as semaglutide (Ozempic/Wegovy) — ...